// App-Quantinova.ai

TCT-469 : The Long-term Impact of Antiplatelet Therapy Interruption on Stent Thrombosis Following Percutaneous Coronary Intervention with the Resolute Zotarolimus-eluting Stent

Researchers

Presenter

  • Ajay J. Kirtane

Principal Investigators

  • Sigmund Silber

  • Sandeep Brar

  • Stephan Windecker

Medical Centers

  • Heart Center at the Isar, Munich, Germany

  • New York-Presbyterian/Columbia University Medical Center, Manhasset, NY

  • IBCSG and University Hospital, Berne, Switzerland

Locations

  • United States

  • Germany

  • Switzerland

Companies

  • Medtronic Plc

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

Disease

  • Acute Coronary Syndromes

  • Venous thrombosis

  • Diabetes

Biomarkers

  • N/A

Drug/Treatment

  • ZoMaxx

  • Aspirin

  • Albyl-E

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved